AB Science shares fall 5.5%, but remain up 22.5% over the week
The Paris-based biotech is losing ground at midday, after several sessions of sharp rebound that had lifted it among the most sought-after stocks on the exchange. The decline occurs in a stable Parisian market, which isolates the move from the rest of the market.
A 5.57% decline that barely dents the 22% weekly gain
AB Science shares fall 5.57% to €0.64 intraday, compared with €0.68 at the previous close, while the CAC 40 is virtually unchanged at 8,363 points.
The stock nonetheless remains up 22.39% over seven days, which limits the significance of the day's decline. Over three months, it still shows -11.76%, and -45.89% over one year.
The move therefore erases only a fraction of the week's rebound: a 5.57% decline does not offset the 22.39% gained. The stock ranks among the largest decliners of the broad CAC All-Shares index, with a final position close to the most penalized stocks of the session, well behind the -17% of the laggard.
The stock remains well above its MA20, below a still-distant MA200
The price remains above the MA20 at €0.55 (a gap of +17.09%) and the MA50 at €0.60 (+7.33%), which provides a cushion after the recent advance. The MA200, at €0.89, remains out of reach: the price is 27.64% below it.
The stock thus ran into resistance at €0.68, the previous day's closing level, before retreating. The RSI at 63 signals a still-bullish configuration in the short term, without excessive overbought conditions. The support at €0.51 is the next level to watch if the decline extends.
